Moody Aldrich Partners »

Definium Therape shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 51k 47.04

More positions owned by Moody Aldrich Partners

Element Solutions (ESI)
Oruka Therapeutics (ORKA)
Independent Bank (INDB)
Wintrust Financial Corporation (WTFC)
Ligand Pharmaceuticals Com New (LGND)
Old National Ban (ONB)
Columbia Banking System (COLB)
Riot Blockchain (RIOT)
Meta Financial (CASH)
Core Scientific (CORZ)
Protagonist Therapeutics (PTGX)
Dianthus Therapeutics (DNTH)
Cipher Mining (CIFR)
Ambiq Micro Common Stock (AMBQ)
Hut 8 Corp (HUT)

View all positions for Moody Aldrich Partners

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape